Cambria Shareholder Yield ETF
SYLD - ETF AI Analysis
Top Page
Cambria Shareholder Yield ETF (SYLD)
SYLD’s overall rating suggests it is a solid but not top-tier ETF, supported by several strong holdings with healthy cash flow, reasonable valuations, and positive strategic momentum. Standout contributors like Maplebear (CART), Pediatrix Medical Group (MD), and PHINIA (PHIN) add strength through robust profitability, improving leverage, and upbeat earnings calls, while weaker names such as Bloomin’ Brands (BLMN) and H&R Block (HRB) weigh on the fund with high leverage, financial challenges, and some bearish technical trends. A key risk for SYLD is its exposure to companies with significant debt and leverage concerns, which could increase volatility if economic conditions worsen.
SYLD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.03B
- Region
- North America
- Expense Ratio
- 0.59%
- Beta
- 0.67
- Issuer
- Cambria
- Inception Date
- May 14, 2013
- Dividend Yield
- 1.70%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
SYLD Summary
Cambria Shareholder Yield ETF (SYLD) is a U.S. stock fund that focuses on companies that return cash to their investors through dividends, stock buybacks, and paying down debt, rather than tracking a specific index. It spreads investments across many sectors, including consumer, financial, energy, and health care companies. Well-known holdings include Allstate and Yelp. Someone might invest in SYLD to get diversified exposure to U.S. companies that actively reward shareholders, aiming for a mix of income and growth. A key risk is that the value of the ETF can rise or fall with the overall stock market and the specific sectors it emphasizes.
How much will it cost me?
SYLD has an annual expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 you invest. This cost is higher than the average ETF because SYLD is actively managed, using a specialized strategy to select companies with strong shareholder yield.
What would affect this ETF?
SYLD could benefit if the U.S. economy stays healthy, consumer spending remains strong, and energy and financial companies continue to generate solid profits and return cash to shareholders through dividends and buybacks. On the other hand, a slowdown in the U.S. economy, rising interest rates that pressure financials and consumer-focused businesses, or new regulations affecting energy and insurance companies could hurt the fund’s performance.
SYLD Top 10 Holdings
SYLD is leaning into U.S. value-style names that are rewarding shareholders, with energy and cyclical stocks doing much of the heavy lifting. APA and ConocoPhillips are rising on solid cash flows and shareholder-friendly policies, giving the fund a strong energy backbone. Retail name Abercrombie & Fitch has been on a tear, adding some consumer flair, while Ryder and SAIC provide steady support from industrial and government services. On the flip side, Maximus has been lagging lately, slightly dragging on performance, but overall the fund’s diversified U.S. mix keeps it balanced.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Adt | 1.51% | $15.46M | $7.23B | 18.14% | 69Neutral | |
| Maplebear | 1.25% | $12.86M | $13.93B | 45.97% | 79Outperform | |
| Travel + Leisure Co | 1.19% | $12.19M | $4.74B | 23.35% | 73Outperform | |
| Bloomin' Brands | 1.18% | $12.08M | $889.25M | 52.72% | 52Neutral | |
| Sirius XM Holdings | 1.17% | $11.98M | $10.72B | 47.45% | 64Neutral | |
| Columbia Sportswear | 1.16% | $11.94M | $3.70B | 34.93% | 69Neutral | |
| Ryder System | 1.14% | $11.72M | $10.78B | 66.57% | 73Outperform | |
| Pediatrix Medical Group | 1.15% | $11.82M | $2.45B | 38.31% | 76Outperform | |
| PHINIA Inc. | 1.16% | $11.87M | $2.64B | 34.21% | 72Outperform | |
| H&R Block | 1.14% | $11.69M | $6.13B | 11.51% | 63Neutral |
SYLD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SYLD, the sentiment is Positive. The current price of 86.19 is above the 20-day moving average (MA) of 85.66, above the 50-day MA of 84.04, and above the 200-day MA of 79.88, indicating a bullish trend. The MACD of 0.67 indicates Positive momentum. The RSI at 54.96 is Neutral, neither overbought nor oversold. The STOCH value of 32.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SYLD.
SYLD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $86.19 | $94.00(9.06% Upside) | $1.03B | 0.59% | 69Neutral | |
| $44.22 | $52.52(18.76% Upside) | $9.04B | 0.50% | 75Outperform | |
| $60.44 | $71.06(17.58% Upside) | $4.91B | 0.98% | 68Neutral | |
| $47.45 | $57.43(21.04% Upside) | $4.69B | 0.34% | 73Outperform | |
| $83.41 | $99.74(19.58% Upside) | $3.68B | 0.14% | 72Outperform | |
| $23.11 | $27.62(19.52% Upside) | $2.58B | 0.75% | 70Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SYLD | Cambria Shareholder Yield ETF | 86.19 | 21.35 | 32.93% | |
| QLTY | GMO U.S. Quality ETF | 44.22 | 7.68 | 21.03% | |
| AKRE | Akre Focus ETF | 60.44 | -1.91 | -3.06% | |
| TSPA | T. Rowe Price U.S. Equity Research ETF | 47.45 | 5.77 | 13.84% | |
| DCOR | Dimensional US Core Equity 1 ETF | 83.41 | 12.97 | 18.41% | |
| FTHI | First Trust BuyWrite Income ETF | 23.11 | 1.68 | 7.83% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
